A randomized research study sponsored by Washington University School of Medicine seeks participants age 30 and older, who have tested positive for COVID-19, and are currently experiencing mild symptoms.
Search Results for: COVID
Dr. John Aucott, Director of The Lyme Disease Research Center, Division of Rheumatology, Department of Medicine at Johns Hopkins University School of Medicine, et al. published the article, “Long-haul COVID: heed the lessons from other infection-triggered illnesses” in The Lancet.
A peer-reviewed report co-authored by Melissa C Fesler and Raphael B Stricker has been published in the International Journal of General Medicine which evaluates pre-exposure prophylaxis (PrEP) using medications approved for use in pregnant women to prevent gestational problems and severe illness in this high-risk population.
Lyme Test/Lyme Neuropathologies/Military: Lyme Myths/Tick Bite/CDC: COVID Vaccine/Hopkins: IDSA, Lyme-COVID/FDA Clears PhageBank/HHS WG ’20 Report/Lyme Boundaries/Longhorned Tick Spread/J&J Vaccine/Babesiosis Increase
As part of the LymeX public-private partnership between Health & Human Services (HHS) and the Cohen Foundation, HHS has published an RFI in the Federal Register, 2.11.21 that seeks information on the current state of the science and technology to accelerate “innovative solutions” for Lyme disease diagnosis.
Update 2/27/21: The FDA has approved J&J’s Covid-19 vaccine for emergency use Feb. 24, 2021 – the Food & Drug Administration (FDA) has indicated Johnson & Johnson’s COVID-19 vaccine has met requirements for emergency use authorization (EUA). The report from staff will be used to brief the Vaccines & Related Biological Products Advisory Committee meeting, […]
The Centers for Disease Control and Prevention (CDC) has provided an update in the federal agency’s Morbidity and Mortality Weekly Report (MMWR) on February 19, 2021, regarding the first month of COVID-19 vaccine safety monitoring in the US from December 14, 2020 through January 13, 2021. The report covers the two COVID-19 vaccines, developed by Pfizer BioNTech […]
Adaptive Phage Therapeutics (APT) announced the US Food and Drug Administration (FDA) clearance of the Expanded Access IND for PhageBank™ treatment for pneumonia or bacteremia/septicemia due to Acinetobacter baumannii, Pseudomonas aeruginosa or Staphylococcus aureus in COVID-19 patients. APT’s PhageBank™ therapy has been used to treat 9 COVID-19 patients in South Texas with co-infections due to multi-drug resistant Acinetobacter baumannii […]
Johns Hopkins Lyme Disease Research Center’s recently released Winter 2021 Newsletter addresses the confusing new IDSA guidelines, calls attention to the similarities between common COVID-19 long hauler symptoms and persistent Lyme disease, as well as provides insights to significant advances made by their Lyme disease clinical research program, despite challenges brought by the COVID-19 pandemic.
On January 14, 2021, The National Institute of Health (NIH) COVID-19 Treatment Guidelines Panel issued a change in position and are no longer recommending “against” the use of ivermectin for the treatment of COVID-19. This “permission” was issued 8 days after Drs. Paul Marik and Pierre Kory, founding members of the Front Line Covid-19 Critical […]